MétaCan
Menu
Back to cohort
Record W4414907048 · doi:10.1158/2159-8290.cd-24-1213

Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer

2025· article· en· W4414907048 on OpenAlexaff
Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, T. Sudhakar Babu, Chen Weller, Abel González-Pérez, Yuan Wang, Lucas Michel-Todó, Ronen Levy, Xi Chen, Polina Greenberg, Maria Dayan-Rubinov, Elizabeta Yakubovich, Talya Wasserman-Bartov, Mirie Zerbib, Jianhui Gong, Ryan J. Rebernick, Almudena Tercero, Laura Agundez, Gil Benedek, Merav Kedmi, Roni Oren, Shifra Ben‐Dor, Yishai Levin, Olga G. Troyanskaya, Aslı D. Munzur, Alexander W. Wyatt, Marcin Cieślik, David A. Quigley, Eliezer M. Van Allen, Niroshana Anandasabapathy, Joaquı́n Mateo, Xinbo Yang, Francisco Martínez-Jiménez, Núria López-Bigas, Yardena Samuels

Bibliographic record

VenueCancer Discovery · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsCanada's Michael Smith Genome Sciences CentreUniversity of British Columbia
FundersEuropean CommissionIsrael Science FoundationMelanoma Research AllianceHORIZON EUROPE European Research CouncilIsrael Cancer Research Fund
KeywordsProstate cancerImmunotherapyAcquired resistanceReceptorCancerAntigenAntibodyChimeric antigen receptor

Abstract

fetched live from OpenAlex

New approaches that generate long-lasting therapeutic responses in patients with therapy-resistant metastatic cancer are urgently needed. To address this challenge, we developed Spot Neoantigens in Metastases (SpotNeoMet), a novel data-driven pipeline that systematically identifies recurrently presented neopeptides in treatment-resistant patients. We identified seven therapy resistance mutations predicted to produce neopeptides presented by common HLAs. Using HLA immunopeptidomics, we discovered three novel neopeptides derived from androgen receptor (AR) H875Y, a common metastatic castration-resistant prostate cancer (mCRPC) mutation. We validated these neoantigens as highly immunogenic and then isolated and characterized cognate T-cell receptors (TCR) from healthy donor peripheral blood mononuclear cells. We demonstrated that AR H875Y-specific TCRs are highly specific and kill prostate cancer cells presenting AR neopeptides in vitro and in vivo. Our new pipeline identifies novel immunotherapy targets and potential treatment options for patients with mCRPC. Moreover, SpotNeoMet offers a systematic route to identify "HLA-peptide" pairs and their cognate TCRs across treatment-resistant cancers. SIGNIFICANCE: As the emergence of resistance to targeted treatments in patients with metastatic cancer, there is an urgent need for innovative therapeutic approaches for this population. Our study provides a new analytic framework to identify neoantigens from treatment-resistant mutations and a proof-of-concept T cell-based immunotherapy treatment for mCRPC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.572
Threshold uncertainty score0.905

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.292
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer DiscoverySame topicCancer Immunotherapy and BiomarkersFrench-language works237,207